These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16391129)

  • 1. Gene targeting in the Gram-Positive bacterium Lactococcus lactis, using various delta ribozymes.
    Fiola K; Perreault JP; Cousineau B
    Appl Environ Microbiol; 2006 Jan; 72(1):869-79. PubMed ID: 16391129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic cleavage of cis- and trans-acting antigenomic delta ribozymes in the presence of various divalent metal ions.
    Wrzesinski J; Legiewicz M; Smólska B; Ciesiolka J
    Nucleic Acids Res; 2001 Nov; 29(21):4482-92. PubMed ID: 11691936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target-induced SOFA-HDV ribozyme.
    Lévesque MV; Perreault JP
    Methods Mol Biol; 2012; 848():369-84. PubMed ID: 22315081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta ribozyme has the ability to cleave in transan mRNA.
    Roy G; Ananvoranich S; Perreault JP
    Nucleic Acids Res; 1999 Feb; 27(4):942-8. PubMed ID: 9927724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient trans cleavage and a common structural motif for the ribozymes of the human hepatitis delta agent.
    Branch AD; Robertson HD
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10163-7. PubMed ID: 1946436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of the most potent specific on/off adaptor-hepatitis delta virus ribozymes for use in gene targeting.
    Lévesque MV; Rouleau SG; Perreault JP
    Nucleic Acid Ther; 2011 Aug; 21(4):241-52. PubMed ID: 21793786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenomic Hepatitis delta virus ribozymes self-cleave in 18 M formamide.
    Smith JB; Dinter-Gottlieb G
    Nucleic Acids Res; 1991 Mar; 19(6):1285-9. PubMed ID: 1709487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme.
    Asif-Ullah M; Lévesque M; Robichaud G; Perreault JP
    Curr Gene Ther; 2007 Jun; 7(3):205-16. PubMed ID: 17584038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of the SOFA delta ribozyme.
    Bergeron LJ; Reymond C; Perreault JP
    RNA; 2005 Dec; 11(12):1858-68. PubMed ID: 16251383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of antigenomic hepatitis delta virus ribozyme cis- and trans- analogs.
    Savochkina L; Alekseenkova V; Belyanko T; Lukin M; Beabealashvilli R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):935-42. PubMed ID: 15560085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-acting antigenomic HDV ribozyme for production of in vitro transcripts with homogenous 3' ends.
    Szafraniec M; Blaszczyk L; Wrzesinski J; Ciesiolka J
    Methods Mol Biol; 2012; 941():99-111. PubMed ID: 23065556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A toggle duplex in hepatitis delta virus self-cleaving RNA that stabilizes an inactive and a salt-dependent pro-active ribozyme conformation.
    Perrotta AT; Been MD
    J Mol Biol; 1998 Jun; 279(2):361-73. PubMed ID: 9642043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic strategies of the hepatitis delta virus ribozymes.
    Shih IH; Been MD
    Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking experiments reveal the presence of novel structural features between a hepatitis delta virus ribozyme and its substrate.
    Ouellet J; Perreault JP
    RNA; 2004 Jul; 10(7):1059-72. PubMed ID: 15208442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One sequence, two ribozymes: implications for the emergence of new ribozyme folds.
    Schultes EA; Bartel DP
    Science; 2000 Jul; 289(5478):448-52. PubMed ID: 10903205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage.
    Deschênes P; Lafontaine DA; Charland S; Perreault JP
    Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):53-61. PubMed ID: 10726661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.